Nature Publishing Group, publisher of Nature, and other science journals and reference works
Bioentrepreneur home
my accounte-alertssubscriberegister
SEARCH SITEadvanced search
Home
Bioe News
Building a Business
Entrepreneurship
Intellectual property
Technology transfer
Finance
Business planning
Partners
Infrastructure
Human resources
Public relations
Managing risk
Regional initiatives
View from the Inside
Start-up Profiles
Tool Kit
Naturejobs
Natureevents
Sponsors
About this Site
 Resources
 Nature
 Nature
 Biotechnology
 Biotech Directory
 Nature Reviews
 Drug Discovery
 news@nature.com
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 

Building a Business > Regional initiatives

Many countries are keen to jump on the biotechnology bandwagon. This section provides descriptions of development initiatives at the local, regional, national and international level that have encouraged the founding of life science ventures across the globe.

Realizing potential: the state of Asian bioentrepreneurship
April 2003
An overview of biotechnology entrepreneurship activities in the Asia-Pacific region, where the industry is colorful and diverse, and the development potential is enormous.

Success from a virtual structure
May 1999
A virtual organization coordinating the resources of 170 companies and research institutes is providing a dramatic push forward for German biotechnology.

Not enough biotechs, and what government can do about it
May 1999
While financial markets may believe there are too many biotechnology companies in the world, research suggests that the opposite is true.

Financing biotech ventures in Scandinavia
May 1999
Scandinavia's Medicon Valley is experiencing a spurt of funding, prompted by a combination of government and private capital.

Is consolidation the only option for UK biotech?
May 1999
Yes, if it is to have the resources needed to develop products of interest to large pharmaceutical partners.

 more articles


Home | Bioe News | Building a Business | View from the Inside
Start-up Profiles | Tool Kit | Naturejobs | Natureevents | Sponsors | About this Site
© 2003 - 2004 Nature Publishing Group
Privacy Policy